Clinical Trial

Improvement of Women's Health After Allogeneic Stem Cell Transplantation

Study acronym: SaFeGreff
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this prospective research project is to better understand vulvovaginal cGVHD to improve care of allografted women. The expected outcomes include better knowledge of the incidence and manifestations of vulvovaginal cGVHD, risk factors, response to treatments and impact on sexual health of allotransplanted female patients. The knowledge acquired will allow transplant clinicians to make more precise recommendations for gynecological management of future allografted women.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-19; most recent amendment 2026-03-16.
Status change: Not Yet Recruiting → Recruiting 2026-03-16
Trial Details
NCT Number NCT06279676
Lead Sponsor Ciusss de L'Est de l'Île de Montréal
Collaborators: Centre hospitalier de l'Université de Montréal (CHUM)
Conditions GVHD, Chronic
Enrollment 100 participants
Start Date 2024-08-27
Primary Completion 2028-07 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-18